Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Trump may slash China tariffs to 50% as US-China trade talks heat up: report
Economy

Trump may slash China tariffs to 50% as US-China trade talks heat up: report

The United States is considering a major rollback of tariffs on Chinese imports, with plans underway to cut the current 145% levy to as low as 50%, according to a report by the New York Post. The potential move signals a significant shift in the Trump administration’s trade strategy as high-level negotiations between US and […]

  • May 08, 2025 01:15 PM PDT
  • Invezz
Celldex: Q1 Earnings Snapshot
Market Updates

Celldex: Q1 Earnings Snapshot

HAMPTON, N.J. (AP) — HAMPTON, N.J. (AP) — Celldex Therapeutics Inc. (CLDX) on Thursday reported a loss of $53.8 million in its first quarter. The Hampton, New Jersey-based company said it had a loss o...

  • May 08, 2025 01:14 PM PDT
  • EODHD
Uber's Upside Potential Limited Amid Lack of Catalysts, Wedbush Says in Downgrade
Market Updates

Uber's Upside Potential Limited Amid Lack of Catalysts, Wedbush Says in Downgrade

Uber Technologies' (UBER) stock lacks near-term drivers for a potential upside, Wedbush Securities s PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscripti...

  • May 08, 2025 01:10 PM PDT
  • EODHD
Angi to Participate in the 53nd Annual J.P. Morgan Global Technology, Media and Communications Conference
Market Updates

Angi to Participate in the 53nd Annual J.P. Morgan Global Technology, Media and Communications Conference

DENVER, May 08, 2025 (GLOBE NEWSWIRE) -- Angi Inc. (NASDAQ: ANGI) will participate in the 53nd Annual J.P. Morgan Global Technology, Media and Communications Conference on Thursday, May 15, 2025. CEO...

  • May 08, 2025 01:10 PM PDT
  • EODHD
McKesson Reports Fiscal 2025 Fourth Quarter and Full Year Results and Provides Fiscal 2026 Guidance; Announces Intent to Separate Medical-Surgical Solutions
Market Updates

McKesson Reports Fiscal 2025 Fourth Quarter and Full Year Results and Provides Fiscal 2026 Guidance; Announces Intent to Separate Medical-Surgical Solutions

IRVING, Texas, May 08, 2025--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 fourth quarter financial results. Results can be accessed on McKesson’s Investor Relations w...

  • May 08, 2025 01:10 PM PDT
  • EODHD
BUCCANEERS PARTNER WITH RUMBLE CLOUD
Market Updates

BUCCANEERS PARTNER WITH RUMBLE CLOUD

LONGBOAT KEY, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Today, the Tampa Bay Buccaneers announced a partnership with Rumble (NASDAQ: RUM), the video sharing platform and cloud services provider. The Buccan...

  • May 08, 2025 01:10 PM PDT
  • EODHD
Root, Inc. to Participate in the 2025 Wells Fargo Financial Services Investor Conference
Market Updates

Root, Inc. to Participate in the 2025 Wells Fargo Financial Services Investor Conference

Root, Inc. COLUMBUS, Ohio, May 08, 2025 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ: ROOT), a leading technology company powering insurance solutions and the parent company of Root Insurance, today announc...

  • May 08, 2025 01:05 PM PDT
  • EODHD
Tripadvisor Announces Participation at Upcoming Conferences
Market Updates

Tripadvisor Announces Participation at Upcoming Conferences

NEEDHAM, Mass., May 8, 2025 /PRNewswire/ -- Tripadvisor, Inc. (NASDAQ: TRIP) announced today its participation in the following upcoming investor conferences:(PRNewsfoto/Tripadvisor) Mike Noonan, CFO,...

  • May 08, 2025 01:05 PM PDT
  • EODHD
Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15
Market Updates

Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15

DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for s...

  • May 08, 2025 01:05 PM PDT
  • EODHD
Soleno Therapeutics Announces Oral Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ESPE and ESE 2025
Market Updates

Soleno Therapeutics Announces Oral Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ESPE and ESE 2025

Soleno Therapeutics REDWOOD CITY, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatmen...

  • May 08, 2025 01:05 PM PDT
  • EODHD